DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Potency (pharmacology)
Potency (pharmacology)
Exploring the Concept of Safety and Tolerability
Bugs, Drugs, and Cancer: Can the Microbiome Be a Potential
Live Biotherapeutic Products, a Road Map for Safety Assessment
Pharmacology Part 2: Introduction to Pharmacokinetics
Pharmacokinetic Models to Characterize the Absorption Phase and the Influence of a Proton Pump Inhibitor on the Overall Exposure of Dacomitinib
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification
Receptor Af®Nity and Potency of Non-Steroidal Antiandrogens: Translation of Preclinical ®Ndings Into Clinical Activity
NIH Public Access Author Manuscript Chem Biol
Today's Topic
Multidrug-Resistant Gram-Negative Bacteria: How to Treat and for How Long Helen Giamarellou
Challenges of Antibacterial Discovery Lynn L
DOSE-EFFECT RELATIONSHIP Drug Receptor K1 K2 Drug-Receptor
The Role of Epigenomics in Personalized Medicine
Sirtuins in Alzheimer's Disease: SIRT2-Related Genophenotypes and Implications for Pharmacoepigenetics
Pharmacology Part 1: Introduction to Pharmaoclogy and Pharmacodynamics
A Two-Point IC50 Method for Evaluating the Biochemical Potency of Irreversible Enzyme Inhibitors
Pd-Catalyzed Mizoroki-Heck Reactions Using Fluorine-Containing Agents As the Cross-Coupling Partners
Prodrugs Extend the Half Life and Potency of Cabotegravir Tanmay A
Top View
Oleic Acid Produces Motor Incoordination and Hypoactivity in Infant Wistar Rats Through GABAA Receptors
The Clinical Link Between Human Intestinal Microbiota and Systemic Cancer Therapy
Time Course for the Induction and Maintenance of Tolerance to D9-Tetrahydrocannabinol in Mice
Foundations in Pharmacokinetics
Engineering a Long-Acting, Potent GLP-1 Analog for Microstructure-Based Transdermal Delivery
Guidance for Industry Developing Medical Imaging Drug and Biological Products Part 1: Conducting Safety Assessments
Current Concepts and Treatments of Schizophrenia
Glyco-Engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice
Treatment of Infections Caused by Multidrug-Resistant Gram-Negative
Potency and Efficacy (Effectiveness) - Therapeutic Index
Pdf); International Conference on Harmonization, 2012 Comparison of Plasma Profiles Is Shown in Fig
Chapter 1 General Principles of Drug Action 3
Epigenetics in Society
Spero Therapeutics Initiates First Clinical Study of Lead Potentiator Candidate for the Treatment of Multidrug Resistant Gram-Negative Infections
HST-151 1 PRINCIPLES of PHARMACOKINETICS Learning
Exploring the Emerging Role of the Microbiome in Cancer Immunotherapy Jessica Fessler1†, Vyara Matson1† and Thomas F
From Drug Combinations to Epigenetic Editing
Environmental Chemicals, the Human Microbiome, and Health Risk: a Research Strategy